Sunpeaks Ventures Announces Clotamin available on Walgreens.com
SILVER SPRING, Md., March 19, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTC Bulletin Board: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialist, LLC ("HDS") are pleased to announce that Clotamin® is now available on Walgreens.com.
"The addition of Walgreens.com is an important step for the distribution of Clotamin. Clotamin has a significant market to reach and this is just another step in the process," stated Mackie A. Barch, CEO of Sunpeaks. "We couldn't be more excited to have our product available on Walgreens.com."
Clotamin® is the world's first specialized OTC multivitamin product designed exclusively for use by patients on Warfarin® or other anticoagulants (blood thinners). According to BioMed Trends, in a report released by Global Industry Analysts, Inc., the global anticoagulants market is projected to surpass $11.2 billion by the year 2015, driven by an aging global population, rising incidence of cardiovascular diseases, cancers, and acute hip and knee complications, as well as emergence of innovative therapeutics targeting new and previously targeted clotting factors.
About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.